Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.15B |
| 2 |
Tesla
TSLA
|
+$1.26B |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$610M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$652M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 4 |
Meta Platforms (Facebook)
META
|
+$583M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
+$507M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.96% |
| 2 | Consumer Discretionary | 3.1% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 1.15% |
| 5 | Communication Services | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
First Trust Rising Dividend Achievers ETF
RDVY
$25.5B
| $1.58M | ﹤0.01% |
33,614
-15,836
| -32% | -$716K |
|
|
THS
4477
DELISTED
Treehouse Foods
THS
| $1.58M | ﹤0.01% |
31,409
+23,279
| +286% | +$1.19M |
|
4478
Clear Secure
YOU
$5.27B
| $1.58M | ﹤0.01% |
68,265
-2,070
| -3% | -$51.2K |
|
4479
PUT
Bausch Health
BHC
$2.37B
| $1.58M | ﹤0.01% |
197,700
+21,700
| +12% | +$160K |
|
4480
Tredegar Corp
TG
$292M
| $1.58M | ﹤0.01% |
+237,053
| New | +$1.88M |
|
4481
CALL
Alkermes
ALKS
$8.29B
| $1.58M | ﹤0.01% |
50,500
-78,000
| -61% | -$2.36M |
|
4482
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.31B
| $1.58M | ﹤0.01% |
+61,902
| New | +$1.56M |
|
4483
Triumph Financial Inc
TFIN
$1.8B
| $1.58M | ﹤0.01% |
26,001
-3,755
| -13% | -$206K |
|
|
ACLX
4484
PUT
DELISTED
Arcellx
ACLX
| $1.58M | ﹤0.01% |
+49,900
| New | +$1.91M |
|
4485
PUT
Illinois Tool Works
ITW
$83.9B
| $1.58M | ﹤0.01% |
6,300
+3,100
| +97% | +$726K |
|
4486
CALL
Intellia Therapeutics
NTLA
$1.68B
| $1.57M | ﹤0.01% |
38,600
-22,200
| -37% | -$900K |
|
4487
CALL
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
| $1.57M | ﹤0.01% |
83,600
-113,700
| -58% | -$2.14M |
|
4488
CALL
Amplify Online Retail ETF
IBUY
$126M
| $1.57M | ﹤0.01% |
69,100
-35,100
| -34% | -$1.5M |
|
|
PGTI
4489
DELISTED
PGT, Inc.
PGTI
| $1.57M | ﹤0.01% |
53,857
+28,676
| +114% | +$755K |
|
4490
Invesco KBW Bank ETF
KBWB
$6.75B
| $1.57M | ﹤0.01% |
38,189
+12,364
| +48% | +$503K |
|
4491
Aclaris Therapeutics
ACRS
$867M
| $1.57M | ﹤0.01% |
151,035
-26,426
| -15% | -$239K |
|
|
TCN
4492
DELISTED
Tricon Residential Inc.
TCN
| $1.56M | ﹤0.01% |
177,344
+108,295
| +157% | +$885K |
|
|
AGEN
4493
Agenus
AGEN
$291M
| $1.56M | ﹤0.01% |
48,795
+19,647
| +67% | +$629K |
|
4494
CALL
Groupon
GRPN
$933M
| $1.56M | ﹤0.01% |
264,000
+140,700
| +114% | +$623K |
|
4495
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$32.7M
| $1.56M | ﹤0.01% |
11,140
-426
| -4% | -$61.9K |
|
4496
PUT
Zimmer Biomet
ZBH
$18.7B
| $1.56M | ﹤0.01% |
+10,700
| New | +$1.45M |
|
|
FOLD
4497
DELISTED
Amicus Therapeutics
FOLD
| $1.56M | ﹤0.01% |
124,003
+18,665
| +18% | +$221K |
|
|
EXK
4498
Endeavour Silver
EXK
$3.03B
| $1.56M | ﹤0.01% |
538,906
+167,862
| +45% | +$593K |
|
|
KMET
4499
DELISTED
KraneShares Electrification Metals Strategy ETF
KMET
| $1.56M | ﹤0.01% |
68,064
-683,651
| -91% | -$16.3M |
|
4500
PUT
Lumentum
LITE
$63.3B
| $1.55M | ﹤0.01% |
27,400
+15,900
| +138% | +$795K |
|
Similar funds
Jane Street's Q2 2023 Portfolio in Review
As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
- Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
- Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
- Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
- Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
- Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.
Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.